MDxHealth SA (NAS:MDXH)

Q3 2025 MDxHealth SA Earnings Call Transcript

Nov 12, 2025 / 09:30 PM GMT

Release Date Price: $4.12 (-7.42%)

Transcript

Key Points

Positve

MDxHealth SA (MDXH) reported an 18% revenue growth in Q3 2025, reaching $27.4 million compared to the previous year.
The company achieved a positive adjusted EBITDA of $1 million in Q3, marking its second consecutive profitable quarter.
Gross margins improved to 65.2% from 61.2% in the previous year, attributed to improved efficiencies and test mix.
The acquisition of the exosome diagnostics business positions MDxHealth SA (MDXH) as a leader in precision diagnostics in urology.
The sales organization expanded from 50 to 60 direct sales reps, optimizing cross-selling opportunities and enhancing customer engagement.

Negative

The company decided to forego its previously planned germline offering, impacting expected revenue contributions for the second half of the year.
Despite the acquisition, MDxHealth SA (MDXH) maintained its revenue guidance, indicating potential conservatism or challenges in realizing immediate revenue growth from the acquisition.
There was a noted sequential decline in average selling price (ASP) for tissue-based tests, raising concerns about pricing stability.
The integration of the exosome diagnostics business requires significant focus and resources, potentially diverting attention from other growth initiatives.
The company experienced a slight increase in operating expenses, up 1% year-to-date, while absorbing acquisition-related costs.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MDXH.OQ - MDxHealth SA
Q3 2025 MDxHealth SA Earnings Call
Nov 12, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning ladies and gentlemen, and welcome to the MDX Health 3rd quarter 2025 earnings conference call.

At this time, all participants are in the listen-only mode. Following the presentation this morning, they will be in question answer session.

To ask a question, we press star and then one on your touchstone phone.

To withdraw your question, we press star and 2.

As a reminder, this call is being recorded.

I would now like to hand over the conference to John Francis from Lifesty Advisors.

Thank you and over to you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
---------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.